Aurobindo Pharma gets US FDA nod for Nafcillin injections
Aurobindo Pharma on Thursday said it has received final approval from US Food and Drugs Administration to manufacture and market Nafcillin for Injection packaged in 1g and 2g vials and Nafcillin for Injection in 10g/vial pharmacy bulk package.
December 27, 2012 / 11:08 IST
Moneycontrol Bureau
Aurobindo Pharma on Thursday said it has received final approval from US Food and Drugs Administration to manufacture and market Nafcillin for Injection packaged in 1g and 2g vials and Nafcillin for Injection in 10g/vial pharmacy bulk package.Nafcillin is an antibiotic in the penicillin group of drugs and is indicated in the treatment of infections caused by staphylococci bacteria.These ANDAs have been approved out of Unit XII formulation facility in Hyderabad and will be marketed and sold by US subsidiary AuroMedics Pharma LLC, Aurobindo said.The company now has 171 ANDA approvals, including 26 tentative approvals, from US FDA.On Monday, It had announced US FDA approval to manufacture and market Ondansetron Injection 2mg/ml strength packaged in 40mg/20ml multiple dose vials and 4mg/2ml single dose vials. It was the first ANDA approved out of the unit IV formulation facility in Hyderabad.Aurobindo Pharma shares were up 0.4 percent at Rs 194 on NSE in morning trade. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
